Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Methods and systems to accomplish variable width data input
Position detection device, pointing device and input device
Decision management system and method
Data output apparatus and data output method
Polypeptide microparticles
Magnetic levitation motor used in lens module
Method to quantify siRNAs, miRNAs and polymorphic miRNAs
  Randomly Featured Patents
Refrigerant recovery system
Multilevel thresholding for target tracking apparatus
Devices for creating voids in interior body regions and related methods
Sub-frame synchronized residual ranging
Cleaving laser diode bars having gratings
Process for the continuous production of lower aliphatic alcohols
Prepolymerized catalyst components for the polymerization of olefins
Driver alert system for the steering wheel of a motor vehicle
Device for measuring optical frequency modulation characteristics
Method for hydrogenation of polymer